Neogen Corp. Hits New 52-Week High of $11.43, Signaling Recovery

Neogen Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 11.43 on February 25, 2026. This achievement marks a notable rebound from its 52-week low of USD 3.87, showcasing the stock's recent upward momentum. Despite a challenging year, with a performance decline of 30.03%, Neogen Corp. has managed to capture attention with this new high. The company's market capitalization stands at USD 2,465 million, reflecting its position within the small-cap segment. Financial metrics indicate a price-to-earnings (P/E) ratio of 31.00, while the return on equity is reported at 0.63%. The company maintains a debt-to-equity ratio of 0.31, suggesting a relatively stable financial structure. As Neogen Corp. continues to navigate the competitive landscape of the pharmaceuticals and biotechnology industry, this recent price milestone underscores its current market activity and performance indicators.